Loading
Wakamoto Pharmaceutical Co.,Ltd.: what insiders have been doing
Every trade that managers of Wakamoto Pharmaceutical Co.,Ltd. disclose to EDINET (Japan FSA) is tracked on this page. The company is based in Tokyo, Japan. It was founded in 1933. In the past year (18 October 2025 to 18 October 2026), 2 filings came from 1 insider.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
There has been no open-market purchase by an insider of Wakamoto Pharmaceutical Co.,Ltd. for at least a year.
Across the 3,419 companies tracked on its exchange, the median is 3 filings; at 2 filings, this issuer sits below that mark.
Every figure here comes from the filings published by EDINET (Japan FSA) and describes the past, not future prices; it is not investment advice.
Key facts
Headquarters: Tokyo, Japan · Founded: 1933
Source: Wikidata (CC0).
Insider Decl.
6
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 15,403 of 23,476 companies
41.5
score / 100
Value31
Quality52
FCF yld-11%
Earn yld2.2%
EV/EBITDA15.6x
ROE-1.8%
Gross mgn48%
Net mgn2.3%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
JP¥301
Analyst consensus
Income statement
RevenueJP¥9.9B
Gross profitJP¥4.7B48% margin
EBITDAJP¥701.2M7% margin
Net incomeJP¥227.2M-2.4% margin
Valuation
PER (trailing)46.0x
P/Book0.9x
Beta0.45
Balance sheet & cash
Market capJP¥10.4B
Total debtJP¥400M
Free Cash Flow-JP¥1.1B
Debt / Equity14%
Profitability & ownership
ROE-1.8%
ROA-1.8%
% insiders43.9%
% institutions20.5%
Last declaration on 27 August 2026
Declarations6 total
23.8% of flowShareXTKSEDINET:S100YY80
21.9% of flowShareXTKSEDINET:S100XDZ6
22.5% of flowShareXTKSEDINET:S100VU0B
17.7% of flowShareXTKSEDINET:S100VC8O
14.1% of flowShareXTKSEDINET:S100VAJU
100.0% of flowShareXTKSEDINET:S100V87D
6 of 6 declarations
About Wakamoto Pharmaceutical Co.,Ltd.
Wakamoto Pharmaceutical Co., Ltd. is a Japanese company engaged in the production of pharmaceutical products. It is listed on the XTKS market.